Clinical Research

Overview

Crowell offers our clients sophisticated guidance on the complex issues encountered by organizations involved in clinical research and use of clincial data. Our advisory services span the  complex regulatory and legal landscape that impacts clinical research across all stages of clincial research, covering issues from regulatory complaince, clincial research programs, secondary use of clincial data and complex transactions and agreements. 

Our clinical research clientele encompasses a diverse spectrum of clients, including academic medical centers, pharmaceutical companies, health care systems, Institutional Review Boards (IRBs), clincial research organizations, laboratories, scientific research consortia, and research foundations. We also have experience with issues involving the protection of particularly vulnerable subjects in research, including prisoners, wards of the state and other children, and individuals with impaired decision‐making ability.

Our work includes:

  • Clinical research and clinical trials compliance, including conducting compliance evaluations of clinical research programs, providing support in addressing federal and state audits and investigations related to scientific research activities.
  • Providing regulatory advice for all aspects of clinical research, including clinical trial strategy support, management systems, diversity in clincial research, guidance on pharmaceutical device and product development, and workforce training.
  • Negotiation of research related arrangements, including engaging in the negotiation and preparation of grants and contracts with both governmental and industrysponsors, IRBs, and other entities involved in clinical research such as clincial research organizations and other vendors.
  • Developing clinical research policies, such as creating and implementing policies and procedures specifically tailored to clinical research in the life sciences sector within the United States and outside the United States.
  • Drafting and negotiating IRB agreements, including preparing and negotiating agreements with IRBs to ensure ethical and regulatory compliance in clinical research.
  • FDA regulation of clinical research products, by understanding and adhering to FDA regulations concerning the development, testing, and approval of drugs, medical devices, and biologics.
  • Managing conflicts of interest in clinical research, by identifying and managing potential issues that may arise in clinical research to maintain integrity and transparency.
  • Providing guidance on research terms, conditions, and cost principles specific to clinical research projects.
  • Ownership and access to clinical research data, including addressing issues related to the ownership, access, and sharing requirements of research and health data, such as the creation of a data repository for future research.

Insights

Firm News | 9 min read | 06.06.24

Crowell Attains Leading Rankings in Chambers USA 2024

Washington – June 6, 2024: Crowell & Moring earned 78 rankings for 67 lawyers, as well as 41 national and statewide practice area rankings, in the Chambers USA 2024 guide. The rankings are driven by independent interviews of clients and lawyers at peer firms....

Representative Matters

  • Helping a major public teaching hospital in New York with developing master research agreements, working with affiliates, handling principal investigators (PIs) who are dually appointed, handling emergency use authorizations and off label reviews, and pursuing new drug approvals from the FDA.
  • Advising digital health company with Software as a Medical Device (SaMD) regulatory questions and advice.
  • Assisting one of the largest pharmaceutical companies in the world with reviewing and drafting clinical trial, research, and data confidentially agreements.
  • Advising a pharmaceutical company regarding FDA regulations and guidance for marketing and advertising of products.
  • Advising a foundation on reviewing and drafting master research agreement and clinical trial agreements around research related to alpha‐1 disease, creating a new consortium as a joint venture with a pharmaceutical company, and drafting consortium agreements dealing with legal and regulatory issues such as the establishment of data and a biorepository and rules around biospecimen data.
  • Helping a major nonprofit hospital network in the southeastern U.S. transition a cancer research consortium from another health care organization. The work on the transaction included setting a data room that all parties to share key documents, performing an extensive due diligence review, drafting assignment and assumption and material and data transfer agreements, and preparing a site assignment notification.
  • Drafting and negotiating manufacturing agreements for a biotechnology company related to the production of the active ingredient and the finished product.
  • Assisting one of the largest pharmaceutical companies in the world with reviewing and drafting clinical trial, research, and data confidentially agreements.
  • Advising digital health company with Software as a Medical Device (SaMD) regulatory questions and advice.
  • Advising a pharmaceutical company regarding FDA regulations and guidance for marketing and advertising of products.
  • Assisting a pharmaceutical company with the creation of a data repository, including reviewing and negotiating data access and licensing agreements, drafting informed consent forms and authorizations, and assisting with IRB related communications and submissions.
  • Drafting and negotiating manufacturing agreements for a biotechnology company related to the production of the active ingredient and the finished product.
  • Assisting a research foundation in partnership with pharmaceutical, life sciences and academic medical center partners in creating and accessing a large-scale data repository and biorepository and drafting research protocols, consent forms and agreements among the parties.
  • Advising a large pharmaceutical company on genetic data privacy matters related to clinical research.

Insights

Firm News | 9 min read | 06.06.24

Crowell Attains Leading Rankings in Chambers USA 2024

Washington – June 6, 2024: Crowell & Moring earned 78 rankings for 67 lawyers, as well as 41 national and statewide practice area rankings, in the Chambers USA 2024 guide. The rankings are driven by independent interviews of clients and lawyers at peer firms....

|

Insights

Firm News | 9 min read | 06.06.24

Crowell Attains Leading Rankings in Chambers USA 2024

Washington – June 6, 2024: Crowell & Moring earned 78 rankings for 67 lawyers, as well as 41 national and statewide practice area rankings, in the Chambers USA 2024 guide. The rankings are driven by independent interviews of clients and lawyers at peer firms....

Insights

Firm News | 9 min read | 06.06.24

Crowell Attains Leading Rankings in Chambers USA 2024

Washington – June 6, 2024: Crowell & Moring earned 78 rankings for 67 lawyers, as well as 41 national and statewide practice area rankings, in the Chambers USA 2024 guide. The rankings are driven by independent interviews of clients and lawyers at peer firms....